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Utilization of Adipose Tissue Biopsy in
Characterizing Human Halogenated
Hydrocarbon Exposure
by Henry A. Anderson*
Halogenated hydrocarbons have been successfully utilized for pest control in agriculture and public
health. In industry, the polychlorinated biphenyls (PCBs) have been particularly useful. Unfortunately,
residues have proven persistent and have been found widely dispersed in the environment. Because they
have chemical properties that favor bioaccumulation, it is not surprising that many have been identified in
animals and man. Such findings prompted public health concern and initiated review ofpotential adverse
health impacts. In many instances this process has led to total prohibition of use or strict limitations.
Highly lipophilic, the primary accumulation site in humans is adipose tissue. Analysis ofadipose samples
remains the preferred biologic index for estimating exposure. Improved instrumentation has lowered the
limit of detection and improved the accuracy of quantification. Accumulated population experience has
helped develop understanding of the dynamics of tissue partitioning in humans. Once such relationships
have been adequately described, other less invasive procedures may be more confidently used for general
surveillance purposes. Whenever adipose tissue is obtained, the blood compartment should also be sampled
and the relationship reported. We have only begun to investigate the resulting partition ratio as an
investigative tool.
Introduction
For the past 50 years, many of the halogenated
aromatic hydrocarbon compounds have enjoyed world-
wide industrial and agricultural utility These com-
pounds have proven to be environmentally stable and
highlypersistent. Those which are least polarandresist
metabolism and excretion readily bioaccumulate. Resi-
dues that have been identified in human biological
specimens (Table 1) collected worldwide have raised
public health concerns (1,2).
The most widely disseminated halogenated com-
pounds which have received the most regulatory atten-
tion can be divided roughly into those used as pesticides
and those with industrial applications: primarily the
PCBs. Once the undesirable persistence and migration
through soil, water, and into the human food chain was
recognized, limiting additional environmental burdens
of pesticides was more amenable to regulation and
control than the circumstances surrounding PCBs. For
pesticides the primary entry into the ecosystem was
through the intended application ofthe product. In the
United States and many other countries, these insecti-
cides have either been completely removed from the
market or severely limited in their use.
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Following the pesticide control model, restricting the
manufacture and utilization ofPCBs was theinitial step
toward limiting escape into the environment. However,
unlike pesticides, vast quantities of PCBs remain in
transformers and other manufactured products still in
use and represent latent exposure potential. When
these products require disposal, they will pose an
additional contamination threat. Already disfunctional
and discarded products exist in dumps and refuse sites
which are now recognized as being unable to prevent
escape of PCB containing leachate or other contami-
nated materials. Controlling future contamination of
Table 1. Halogenated aromatic hydrocarbons and their
metabolites identifiable in human adipose tissue.
Aldrin a-Benzene hexachloride
Dieldrin ,-Benzene hexachloride
Endrin Lindane
Heptachlor -y-Benzene hexachloride
Heptachlor epoxide o,p'-DDT
Oxychlordane p,p'-DDT
trans-Nonachlor o,p'-DDE
Mirex p,p'-DDE
Hexachlorobenzene o,p'-DDD
Polychlorinated biphenyls p,p'-DDD
Polybrominated biphenyls Dioxins
DibenzofuransH. A. ANDERSON
the environment from existing, aging products and
disposal sites has proven difficult.
The polybrominated biphenyls (PBBs) are not widely
disseminated in the environment outside the State of
Michigan. However, PBBs provide auseful studymodel;
and considerable information is available from the
epidemiologic evaluation of the contamination episode.
The dioxins and dibenzofurans fit neither of the
previouslymentioned categories. Theyhave appeared in
the environment as unwanted residual contaminants or
waste by-products from the manufacturing ofother less
environmentally persistent chemicals. Accidents and
fires inindustrial and commercialbuildings have alsoled
to limited contamination. Preventing the entrance of
these chemicals into the environment will be most
difficult.
Evaluation of Techniques Utilized
to Assess Exposure
Highly lipophilic, these compounds preferentially
accumulate in adipose tissue. Depot fat functions as the
primary storage site. Since the human body burden of
these chemicals is in the adipose tissue, generally an
adipose tissue sample has been the preferred biologic
specimen for analysis. Serum and breast milk are the
other frequently collected specimens which are utilized
as proxies for body burden.
There are a number of distinct disadvantages to
reliance upon an adipose biopsy forroutine evaluation of
exposure. Review ofwhat we have learned overthe past
decade is a useful exercise as we plan future surveil-
lance activities and refine the role for utilization of the
adipose tissue biopsy (Table 2).
The foremost disadvantage is in the invasive and
time-consuming procedure necessary to obtain the
specimen. The least objectionable methodology is the
percutaneous needle biopsy which, when the practi-
tioner is experienced, can provide an average of200 mg
of wet weight lipid (3). The sample is usually obtained
from the buttocks. In some individuals, especially the
very thin and the elderly with poor skin turgor, this
technique may be ineffective and produce insufficient
tissue. Extensively utilized by the Environmental Sci-
ences Laboratory ofthe Mount Sinai School ofMedicine
in the evaluation of the PBB episode in Michigan and
studies ofPCB workers, this method was found accept-
able by most of the over 1200 subjects sampled. The
Table 2. Utilization of adipose tissue biopsy.
Advantages Disadvantages
Increased detectability of Invasive technique with risk
body burden
Can utilize autopsy/surgical Serial studies difficult
material
Descriptive epidemiology Time-consuming for mass studies
Direct measurement of body Clinical interpretation difficult
depot
procedure requires 20 to 30 min per sample. Observa-
tional and interview follow-up on a sample of the PBB
exposed individuals found some morbidity, primarily
bruising (greater than 5 cm), persistent pain, and
discomfort at the biopsy site (longer than 48 hr) in 5 to
10% of the subjects. The PBB studies suggested that
females had a greater propensity to develop extensive
bruising.
While serial study of the same individual is possible
with this technique, subject motivation is crucial for
success. Industrial or other high risk groups find the
technique more acceptable than control or general
population groups.
Ifa sample greater than 200 mg is needed because of
technical- laboratory needs (current dioxin analysis
procedures usually request 10-20 g), the alternative is a
surgical biopsy. This is a physician's office or hospital
procedure most often requiring a follow-up visit for
removal of stitches or clips from the biopsy site.
Although morbidity has not been quantified, anecdot-
ally it is reported to be similar to that of the needle
biopsy with the added occasional permanent "dimple" at
the site of tissue removal and the small incision scar.
Resistance to serialstudyis expected tobe greaterthan
to the needle biopsy. Utilization ofthis method has been
limited to small, selected high risk groups.
In the absence ofovert clinical disease or the investi-
gation of possible poisoning, interpreting the clinical
significance ofthe analytical results is difficult. A result
can be placed in descriptive perspective with other
"general population" or occupational group values; but
assigning a future disease risk is still quite speculative.
Despite these drawbacks, the adipose tissue biopsy
remains the reference indicator of exposure tool and
does have several distinct advantages over serum,
whole blood, or breast milk which are the most com-
monly utilized biological materials gathered to assess
exposure to the halogenated hydrocarbons.
Because of the favorable partitioning ratio (lipid to
serum), the high lipid content of adipose tissue allows
increased detectability of body burden. For example
(Fig. 1), had serum PBB beenused alone as anindicator
ofexposure inthe PBB survey ofthe generalpopulation
ofMichigan, only 70% ofthe 839 individuals would have
been considered exposed. When adipose tissue results
are added, an additional 24% indicate exposure, raising
the positive rate to 94%. Even though the limit of
detection was an order ofmagnitude higher(2.0ppb vs.
0.2 ppb in serum), the partition ratio of approximately
300:1 made the adipose limit of detection a more
sensitive indicator of exposure (4).
This increased sensitivity is even more pronounced
when the minimal contamination in the upper peninsula
of Michigan was characterized. Only 19% of the serum
samples were positive compared to 85% of the adipose
samples.(4) However, when human exposure is high and
nearly all serum samples expected positive, the added
sensitivity of adipose samples is less important.
Another advantage of adipose over serum or breast
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FIGURE 1. PBB detection: 839paired serum and adipose tissue sam-
ples, Michigan general population.
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FIGURE 2. PCB adiposetissue distribution estimates; U.S.; allages.
milk is in the ability to utilize autopsy material or
surgical specimens obtained incidental to other proce-
dures. For surveillance programs, such passive systems
are preferable. The National Adipose Tissue Survey of
20 halogenated compounds conducted by the Environ-
mental Protection Agency's National Human Monitor-
ing Program has effectively utilized this approach to
monitor the prevalence and levels of chlorinated pesti-
cides and PCBs in the general population ofthe United
States (5).
Figure 2 summarizes the program's PCB data from
1972 through the first part of 1981. Visually, one can
observe time trends showing a decrease in the percent
of individuals with no detectable PCBs and a slight
increase in the percent ofthose with PCB levels greater
than 3 ppm. Despite the statistical limitations of the
survey methodology, the program has begun to detect
changes over time. Decreases forthe compounds associ-
ated with DDT and increases for PCBs and similar
compounds have been demonstrated through this na-
tional survey program.
More dramatic is the decline in nondetectables in the
under 15 age group (Fig. 3). While the number of
children with detectable levels has increased, the num-
ber with levels above 3 ppm is declining. However, it
may be too early to view this trend from 1979 and 1981
data as definitive. Unfortunately, serial samples from
the same individual are not possible, and thus any
decline in the rate of individual accumulation of PCBs
cannot be directly ascertained. Long-term surveys such
as this play an important role in our assessment of
population dynamics and efforts implemented to de-
crease exposure to these chemicals, and should be able
to provide anindication thatthe rate ofbioaccumulation
has decreased or increased.
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FIGURE 3. PCB adipose tissue distribution estimates under age 15;
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The National Adipose Tissue Survey is an excellent
example of the type of descriptive epidemiology which
has effectively utilized adipose tissue samples. Such
observations have provided geographic, urban, and
rural distributions and demonstrated that women have
lower concentrations than men. Adipose tissue levels of
halogenated hydrocarbons increase with advancing age.
Advancing from descriptive epidemiology to more
analytic epidemiology investigating the relationships
between adipose, serum, and breast milk concentra-
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Table 3. Chlorinated aromatic hydrocarbon adipose tissue
and serum partitioning ratios.
Compound Exposure Partition ratios Reference
PBBs Occupational: males 287:1 Wolff (6)
190-260:1 Eyster (7)
Farmers
Mixed sexes 300:1 Brilliant (8)
Mixed sexes, ages 275:1 Wolff (9)
Mixed sexes, ages 320:1 Wolff (10)
Mixed sexes, ages 363:1 Landrigan (11)
Pregnant females 140-180:1 Eyster (7)
Nonpregnant females 193-230:1 Eyster (7)
Males 325-329:1 Eyster (7)
Michigan general population,
mixed sexes 300:1 Wolff (4)
DDE/DDT General population (DDE) 284:1 Morgan and Roan (12)
Chemical workers (DDE) 230:1 Wolff (6)
Farmers (DDE) 180:1 Wolff (10)
Michigan general population (DDE) 160:1 Wolff (4)
Lindane Occupational 195:1 Baumann (13)
PCBs Occupational (Aroclor 1248) 120:1 Wolff (14)
Occupational (Aroclor 1254) 160:1 Wolff (14)
tionshasbeenhinderedbytheavailability ofcomprehen-
sive data sets. The apparent lack of dose response
relationships in data sets which include health data and
tissue concentration measurements has always been
perplexing. Exposure ranges of four orders of magni-
tude have been described, but human health effects
have not distributed consistently in the anticipated
manner. The question has been raised whether the
current methodology of reporting values accurately
reflects toxicologic potential.
PCBs and PBBs are complex mixtures. Convention
has determined which peaks relative to a commercial
mixture will be quantified to arrive at the composite
concentration used to describe the exposure. As dis-
cussed at this conference, over 40 PCB congeners have
been identified in human adipose tissue, yet they are
combined for descriptive purposes. Ibxicologically they
are far from identical. Current advances in analytic
capability have allowed investigation to begin assessing
individual isomers and how they distribute in human
tissues.
The PBB contamination episode provided an opportu-
nity to study large populations. Although some early
investigations suggested serum and adipose tissue lev-
els did not seem to correlate well with each other, the
studies performed after continuing exposures had
ceased and equilibration had apparently occurred did
find excellent correlation between serum and adipose
levels.
PCBs, DDT and DDE are more widely disseminated
in the environment than PBBs. Table 3 summarizes
most ofthe reports ofpartition ratios between adipose
and serum. It is obvious that the PBB incident in
Michigantriggered considerableresearch; theresults of
these activities have contributed greatly to our under-
standing of how halogenated hydrocarbons partition.
With the exception of the group of pregnant and
nonpregnant women, partitioning ratios for PBBs are
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FIGURE 4. Paired adipose and serum samples: (A) PBB and (0) DDE
concentrations.
quite consistent between studies and fall in the 200-
300:1 adipose to serum range. The range for DDE is
quite similar.
Figure 4 displays the scatterplot of the 27 paired
serum and adipose tissue samples from the 1976 survey
of PBB exposed chemical workers (6). Both the PBB
and DDE paired values are plotted. Although the range
of PBB values is greater than for DDE, the two
distributions visually appear indistinguishable. The
intercepts forthe tworegression equations are 0.357 for
PPB and 0.692 for DDE. However, at serum equal to 10
ppb, the ratio ofadipose to serum is 304:1 for PBB and
349:1 for DDE. The regression lines are statistically
indistinguishable.
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Few paired samples have been reported for correla-
tion of PCB partition ratios (Table 3). Wolff et. al.(14)
reported three groups of partition ratios for PCB
isomers from an occupationally exposed group. The
ratios of adipose to serum ranged from about 80:1 to
200:1. The mixture ofisomers in the exposure becomes
important when interpreting the ratios observed.
Tuey and Matthews (15) have noted the similarity
between the human adipose-serum PBB partition to
that which is predicted bytheir pharmacokinetic animal
model. Their model predicts PBB equilibrium at 340:1.
The differences in the partition ratios reported by the
different authors listed in Table 3 (6-14) may be a
function oftime since exposure. Experience with DDE
and DDTsuggestitmaytake severalyearsforequilibra-
tion to have stabilized. Until equilibrium is reached, the
ratios would be expected to be lower.
Unless acute, high exposures which may significantly
alter equilibrium have occurred prior to testing, all
studies reported a statistically significant correlation
between adipose tissue concentration and serum. Sex,
pregnancy and occupational status appear to affect the
partitioning ratios.
Additional research will be needed to understand the
significance ofobserving different partition ratios. Me-
tabolism of congeners may differ as does toxicity. The
ratio of adipose to serum may become an important
factor in understanding disease potential. The labora-
tory precision in both the adipose and serum analysis
adds variability. Sample size plays an important role in
influencing the stability of the regression equation.
It may be that these factors combined could explain
the different ratios observed. These types of relation-
ships are being actively explored. Utilizing adipose
samples in conjunction with other biologic specimens
adds an important dimension to our understanding.
Conclusion
Unless identification oflow exposures is required, the
close correlation between serum levels and adipose
tissue residues suggests that once the correlation is
characterized, blood samples may be the best choice for
surveillance and monitoring forthese types ofchemicals
(Table 4). Whenever an adipose sample is obtained,
unless from autopsy material, a serum specimen should
also be included and paired results reported. The
combination of these tissue analyses allows a better
understanding of the dynamics and timing of an
Tble 4. Effective utilization of the adipose tissue biopsy in the
evaluation of halogenated aromatic hydrocarbons.
Cases suitable for adipose tissue biopsy
When detection of low level exposure is important
In conjunction with serum analysis, especially when evaluating
suspected clinical poisoning
When autopsy or surgical tissue can be utilized for surveillance
exposure. Partition ratios that are below those reported
from groups expected to be in equilibrium may support
a conclusion that an acute exposure is or has recently
occurred. Ifthis is confirmed, the partition ratio may be
ofutility in evaluating possible continuing environmen-
tal exposures, such as in the vicinity oftoxic dump sites
or other point sources of contamination.
I wish to thank Mary S. Wolff for sharing her experience and
insight; Larry Hanrahan for statistical analyses and graphics and
Diane Johnson and Joan LeClerc for manuscript preparation.
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